What is the interpretation of a Complete Blood Count (CBC) showing erythrocytosis (Red Blood Cell (RBC) count of 6.82 x10E6/uL), hyperhemoglobinemia (Hemoglobin (Hb) of 21.0 g/dL), and elevated hematocrit (61%)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

This patient's CBC results indicate polycythemia, with a hemoglobin level of 21.0 g/dL and hematocrit of 61%, which are above the normal ranges, and therapeutic phlebotomy should be considered if the patient is symptomatic, as per the acc/aha 2008 guidelines 1. The patient's red blood cell count is 6.82 x10^6/μL, which is significantly elevated. Key points to consider in the management of this patient include:

  • The hemoglobin level is above 20 g/dL, which is a criterion for therapeutic phlebotomy in the presence of symptoms such as headache, increasing fatigue, or other symptoms of hyperviscosity, as stated in the acc/aha 2008 guidelines 1.
  • The hematocrit level is 61%, which is below the threshold of 65% recommended for therapeutic phlebotomy by the acc/aha 2008 guidelines 1, but still requires careful evaluation.
  • The patient should be evaluated for symptoms of hyperviscosity, such as headaches, dizziness, or visual disturbances, and referred to a hematologist for further assessment to determine the underlying cause of the polycythemia.
  • Initial management may include therapeutic phlebotomy to reduce blood viscosity and prevent thrombotic complications, as well as hydration to prevent dehydration.
  • Additional testing, such as JAK2 mutation analysis, erythropoietin levels, and bone marrow biopsy, may be necessary to determine whether the patient has polycythemia vera or secondary polycythemia.

From the Research

Interpretation of CBC Results

The provided CBC results show:

  • RBC count: 6.82 x10E6/uL (high)
  • Hemoglobin: 21.0 g/dL (high)
  • Hematocrit: 61 (high)

Possible Causes

Based on the studies, the high RBC count, hemoglobin, and hematocrit levels may indicate polycythemia 2, 3. Polycythemia can be primary (polycythemia vera) or secondary, caused by hypoxic stimuli or other factors.

Characteristics of Polycythemia

  • Primary polycythemia (polycythemia vera) is characterized by an increased RBC mass, often accompanied by an increased white blood cell count and platelet count 2.
  • Secondary polycythemia is often caused by hypoxic stimuli, such as chronic obstructive pulmonary disease (COPD) or sleep apnea 2, 4.
  • An increased hematocrit can be a risk factor for thrombosis, making it essential to diagnose and treat polycythemia promptly 3.

Evaluation and Diagnosis

  • The study by 3 suggests that an hematocrit over 60% in males and over 55% in females is indicative of absolute polycythemia.
  • The presence of splenomegaly, aquagenic pruritus, and erythromelalgia may indicate primary polycythemia (polycythemia vera) 3.
  • Blood volume studies may be necessary to confirm the diagnosis and differentiate between primary and secondary polycythemia 3.

Relationship between MCV, Hematocrit, and Polycythemia

  • The study by 5 highlights the importance of mean corpuscular volume (MCV) in interpreting RBC parameters and evaluating patients with polycythemia.
  • The relationship between MCV, hematocrit, and RBCs is described as a dynamic equilibrium, which can be useful in diagnosing and managing polycythemia 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Mean corpuscular volume, hematocrit and polycythemia.

Hematology (Amsterdam, Netherlands), 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.